Back to Search Start Over

Comparison Between Simultaneous and Sequential Utilization of Safety and Efficacy for Optimal Dose Determination in Bayesian Model-Assisted Designs.

Authors :
Li, Ran
Takeda, Kentaro
Rong, Alan
Source :
Therapeutic Innovation & Regulatory Science; Jul2023, Vol. 57 Issue 4, p728-736, 9p
Publication Year :
2023

Abstract

It has become quite common in recent early oncology trials to include both the dose-finding and the dose-expansion parts within the same study. This shift can be viewed as a seamless way of conducting the trials to obtain information on safety and efficacy hence identifying an optimal dose (OD) rather than just the maximum tolerated dose (MTD). One approach is to conduct a dose-finding part based solely on toxicity outcomes, followed by a dose expansion part to evaluate efficacy outcomes. Another approach employs only the dose-finding part, where the dose-finding decisions are made utilizing both the efficacy and toxicity outcomes of those enrolled patients. In this paper, we compared the two approaches through simulation studies under various realistic settings. The percentage of correct ODs selection, the average number of patients allocated to the ODs, and the average trial duration are reported in choosing the appropriate designs for their early-stage dose-finding trials, including expansion cohorts. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
21684790
Volume :
57
Issue :
4
Database :
Supplemental Index
Journal :
Therapeutic Innovation & Regulatory Science
Publication Type :
Academic Journal
Accession number :
164369780
Full Text :
https://doi.org/10.1007/s43441-023-00517-1